Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Malignant Lymphoma |
Free Subscription
1 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis
of toxicity and impact on CNS relapse.
Am J Hematol. 2024;99:E46-E50.
PubMed
Long-term outcomes with HLX01 (HanliKang((R))), a rituximab biosimilar, in
previously untreated patients with diffuse large B-cell lymphoma: 5-year
follow-up results of the phase 3 HLX01-NHL03 study.
BMC Cancer. 2024;24:124.
PubMed
Abstract available
Out of specification Tisagenlecleucel is associated with outcomes comparable to
standard of care product in relapsed or refractory diffuse large B-cell lymphoma.
Bone Marrow Transplant. 2024 Jan 25. doi: 10.1038/s41409-024-02205.
PubMed
Selective histone deacetylase inhibitor after allo-HCT for T-cell acute
lymphoblastic leukemia or T-cell lymphoma.
Bone Marrow Transplant. 2024 Jan 23. doi: 10.1038/s41409-023-02191.
PubMed
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients
achieving complete response after first-line treatment: A multicentre real-world
analysis.
Br J Haematol. 2024 Jan 25. doi: 10.1111/bjh.19317.
PubMed
Abstract available
New standards of care for treatment of diffuse large B-cell lymphoma.
Br J Haematol. 2024 Jan 22. doi: 10.1111/bjh.19295.
PubMed
Abstract available
The management of newly diagnosed large B-cell lymphoma: A British Society for
Haematology Guideline.
Br J Haematol. 2024 Jan 21. doi: 10.1111/bjh.19273.
PubMed
Mitochondrial-mediated apoptosis as a therapeutic target for FNC
(2'-deoxy-2'-b-fluoro-4'-azidocytidine)-induced inhibition of Dalton's lymphoma
growth and proliferation.
Discov Oncol. 2024;15:16.
PubMed
Abstract available
Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological
pattern and a distinct genomic profile from that of gamma-delta T-cell large
granular lymphocytic leukemia.
Haematologica. 2024 Jan 25. doi: 10.3324/haematol.2023.283856.
PubMed
Abstract available
Accelerating pediatric hodgkin lymphoma research: the hodgkin lymphoma data
collaboration (NODAL).
J Natl Cancer Inst. 2024 Jan 25:djae013. doi: 10.1093.
PubMed
Abstract available
Integration of RNA Sequencing, Whole Exome Sequencing, and Flow Cytometry Into
Routine Diagnostic Workup of Pediatric Lymphomas.
Lab Invest. 2024;104:100267.
PubMed
Abstract available
The impact of marginalization on diffuse large B-cell lymphoma overall survival:
a retrospective cohort study.
Leuk Lymphoma. 2024 Jan 24:1-9. doi: 10.1080/10428194.2024.2306463.
PubMed
Abstract available
Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed,
refractory mantle cell lymphoma.
Leuk Lymphoma. 2024;65:235-241.
PubMed
Abstract available
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK
inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous
system involvement.
Leuk Lymphoma. 2024 Jan 22:1-5. doi: 10.1080/10428194.2024.2304622.
PubMed
Richter transformation - retrospective treatment outcomes analysis in Polish
Adult Leukemia Study Group.
Leuk Lymphoma. 2023 Nov 3:1-12. doi: 10.1080/10428194.2023.2277140.
PubMed
Abstract available
Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis,
NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling.
Mod Pathol. 2024 Jan 22:100428. doi: 10.1016/j.modpat.2024.100428.
PubMed
Abstract available
Thank you for your interest in scientific medicine.